Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Bénard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J, Sommelet D. Rubie H, et al. Among authors: coze c. J Clin Oncol. 1997 Mar;15(3):1171-82. doi: 10.1200/JCO.1997.15.3.1171. J Clin Oncol. 1997. PMID: 9060561
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, Valteau-Couanet D, Plantaz D, Carrie C, Habrand JL, Bergeron C, Chastagner P, Défachelles AS, Delattre O, Combaret V, Bénard J, Pérel Y, Gandemer V, Rubie H; Neuroblastoma Study Group of the French Society of Pediatric Oncology. Laprie A, et al. Among authors: coze c. Cancer. 2004 Sep 1;101(5):1081-9. doi: 10.1002/cncr.20453. Cancer. 2004. PMID: 15329919 Free article.
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O. Valteau-Couanet D, et al. Among authors: coze c. J Clin Oncol. 2005 Jan 20;23(3):532-40. doi: 10.1200/JCO.2005.03.054. J Clin Oncol. 2005. PMID: 15659499 Clinical Trial.
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
Coze C, Hartmann O, Michon J, Frappaz D, Dusol F, Rubie H, Plouvier E, Leverger G, Bordigoni P, Béhar C, Beck D, Mechinaud F, Bergeron C, Plantaz D, Otten J, Zucker JM, Philip T, Bernard JL. Coze C, et al. J Clin Oncol. 1997 Dec;15(12):3433-40. doi: 10.1200/JCO.1997.15.12.3433. J Clin Oncol. 1997. PMID: 9396394 Clinical Trial.
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H, Delattre O, Hartmann O, Combaret V, Michon J, Bénard J, Peyroulet MC, Plantaz D, Coze C, Chastagner P, Baranzelli MC, Frappaz D, Lemerle J, Sommelet D. Rubie H, et al. Among authors: coze c. Eur J Cancer. 1997 Oct;33(12):1917-22. doi: 10.1016/s0959-8049(97)00295-5. Eur J Cancer. 1997. PMID: 9516824
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H, Michon J, Plantaz D, Peyroulet MC, Coze C, Frappaz D, Chastagner P, Baranzelli MC, Méchinaud F, Boutard P, Lutz P, Perel Y, Leverger G, de Lumley L, Millot F, Stéphan JL, Margueritte G, Hartmann O. Rubie H, et al. Among authors: coze c. Br J Cancer. 1998 Jun;77(12):2310-7. doi: 10.1038/bjc.1998.384. Br J Cancer. 1998. PMID: 9649151 Free PMC article. Clinical Trial.
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
Rubie H, Plantaz D, Coze C, Michon J, Frappaz D, Baranzelli MC, Chastagner P, Peyroulet MC, Hartmann O; Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H, et al. Among authors: coze c. Med Pediatr Oncol. 2001 Jan;36(1):247-50. doi: 10.1002/1096-911X(20010101)36:1<247::AID-MPO1061>3.0.CO;2-Z. Med Pediatr Oncol. 2001. PMID: 11464897
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
Rubie H, Coze C, Plantaz D, Munzer C, Defachelles AS, Bergeron C, Thomas C, Chastagner P, Valteau-Couanet D, Michon J, Mosseri V, Hartmann O; Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H, et al. Among authors: coze c. Br J Cancer. 2003 Nov 3;89(9):1605-9. doi: 10.1038/sj.bjc.6601259. Br J Cancer. 2003. PMID: 14583756 Free PMC article.
Neuroblastoma in adolescents.
Gaspar N, Hartmann O, Munzer C, Bergeron C, Millot F, Cousin-Lafay L, Babin-Boilletot A, Blouin P, Pajot C, Coze C. Gaspar N, et al. Among authors: coze c. Cancer. 2003 Jul 15;98(2):349-55. doi: 10.1002/cncr.11521. Cancer. 2003. PMID: 12872356 Free article.
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
Rubie H, Chisholm J, Defachelles AS, Morland B, Munzer C, Valteau-Couanet D, Mosseri V, Bergeron C, Weston C, Coze C, Auvrignon A, Djafari L, Hobson R, Baunin C, Dickinson F, Brisse H, McHugh K, Biassoni L, Giammarile F, Vassal G; Société Françaisedes Cancers de l'Enfant; United Kingdom Children Cancer Study Group-New Agents Group Study. Rubie H, et al. Among authors: coze c. J Clin Oncol. 2006 Nov 20;24(33):5259-64. doi: 10.1200/JCO.2006.06.1572. J Clin Oncol. 2006. PMID: 17114659 Clinical Trial.
126 results